Hear how cancer research has led to vaccines that may prevent cancer and its recurrence and improve the efficacy of cancer treatments.
Nora Disis, MD, associate dean of translational science at the University of Washington and the director of the Cancer Vaccine Institute tells UW Medicine oncologist Shaveta Vinayak, MD about the three goals of the Cancer Vaccine Institute – the largest academic research group dedicated to the development of cancer vaccines:
Prevent cancer from recurring: Cancer recurrence is the major problem for many types of cancer including breast cancer, ovarian cancer and lung cancer.
Improve the effectiveness of cancer treatment: Research has shown a strong immune response can boost the effectiveness of chemotherapy.
Prevent the development of cancer: By targeting specific proteins associated with the development of cancer while simultaneously boosting immune response, researchers are working to prevent cancer from occurring in the first place.
The Cancer Vaccine Institute (CVI) at UW Medicine was established 20 years ago by Dr. Disis, known as the “Mother of Cancer Vaccines,” and is a collaboration of scientists, doctors, nurses, patients and philanthropists all working together to outsmart cancer. Dr. Disis and the team of researchers at the Cancer Vaccine Institute at UW Medicine in Seattle are developing vaccines for breast, colon, ovarian, prostate, pancreatic, sarcoma, lung and bladder cancers.
Find out how your generous gift to the Cancer Vaccine Institute can help us outsmart cancer: online.gifts.washington.edu/peer2peer/Campaign/cvi
Learn more about the Cancer Vaccine Institute at UW Medicine: depts.washington.edu/tumorvac/
Curious about cancer vaccine clinical trials? depts.washington.edu/tumorvac/clinical-trials
Watch the full conversation with Drs. Disis and Vinayak at: youtu.be/n3lSoVPKKFs
CVI’s “multi-antigenic” vaccines target multiple proteins that appear in high levels in cancer tissue and are designed to elicit a specific type of immune system response known to be effective at killing cancer cells. These methods are unique to the CVI and set them apart from other cancer vaccine research.
Researchers at the Cancer Vaccine Institute are closer than ever to making cancer a preventable, treatable condition. But they can’t do it without your generous and visionary support: online.gifts.washington.edu/peer2peer/CampaignDonation?campaignGUID=e433101d-cd60-4b27-8a96-21b32ece165d
- 3 Reasons To Invest In A Breast Cancer Vaccine | UW Medicine Advancement ( Download)
- Frontier Science #20 - Cancer Vaccines & Translational Medicine w/ Nora Disis - Prof. @ UW | BIOS ( Download)
- Applied Immune Profiling: Recent Technical Developments in Monitoring Immune System in Cancer ( Download)
- The 3 W’s of Breast and Cervical Cancer Screening ( Download)
- Your Healthy Family: Possible breast cancer vaccine being studied in people ( Download)
- Taking Down Cancer with Tech ( Download)
- Engineering Better Medicines, Part 3 of 6 ( Download)
- Innovations in Immunotherapy ( Download)
- Exercise Rx - Physical Activity During the COVID Pandemic ( Download)
- Science Cafe - Prostate Cancer - Biomarkers, Prevention Strategies, and Treatment Innovations ( Download)
- Moderna and Merck enter joint venture to develop cancer vaccine ( Download)
- HPV and Cervical Cancer: 25 Years from Discovery to Vaccine ( Download)
- Virtual Pancreas Cancer Awareness Event ( Download)
- Cancer Moonshot: Community Conversations – Moving on Equity: OCE Expands Diversity Initiative ( Download)
- Creating a Cancer Care Map - Part II ( Download)
